• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    6.81 Up 0.15(2.25%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:6.66
    Open:6.66
    Bid:4.87 x 100
    Ask:N/A
    1y Target Est:8.16
    Beta:0.86
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:6.60 - 6.85
    52wk Range:4.90 - 9.83
    Volume:2,807,829
    Avg Vol (3m):7,001,620
    Market Cap:1.27B
    P/E (ttm):N/A
    EPS (ttm):-1.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 2.25%1.27B
    NVSUp 0.71%227.14B
    PFEDown 0.10%197.97B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):26.57
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.10
    Quarterly EPS Est (Dec-14) :-0.27
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.15

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback